A Study in People With High Cholesterol

Lilly

Status and phase: Completed; Phase 2

Conditions: Hypercholesterolemia

Treatments: Drug: placebo; Drug: atorvastatin; Drug: PPAR alpha

Study type: Interventional

Funder types: Industry

Identifiers

NCT00133380

9591

H8D-MC-EMBF

Details and patient eligibility

About

The purposes of this study are to determine:

• The safety of the study medication and any side effects that might be associated with it
• Whether the study medication can help patients with high levels of "bad" cholesterol (low-density lipoprotein-cholesterol [LDL-C]), alone or in combination with additional study medication

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women between 18 and 80 years of age
• People with abnormal cholesterol levels

Exclusion criteria

• People with diabetes
• People whose blood pressure >160/95 mm Hg, on or off blood pressure medicine
• People who have had frequent chest pain or unstable angina, a heart attack or a heart procedure including stent placement, within the past 3 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind